Discover a New Era of clariti® 1 day multifocal

Meet the new clariti® 1 day multifocal 3 Add: CooperVision’s latest innovation1 for patients with presbyopia equipped with a new design, new edge, and new parameters. In day-to-day clinical practice, here’s why CooperVision’s latest innovation in a multifocal matters.

For patients, the clariti® 1 day multifocal 3 Add delivers an improved vision upgrade with Binocular Progressive System™*2 and enhanced comfort with the Optimized Comfort Edge™,2while also providing a seamless, easy fit for eye care professionals,3 says Dr. Matthew Lampa, OD, FAAO, Professor at the Pacific University College of Optometry and associate at Silver Falls Eyecare in Silverton, OR.

“My experience with the new clariti® 1 day multifocal 3 Add has been great,” Dr. Lampa says.  “I’ve been really impressed with its straightforward and simple fitting process.4 The ease of fit makes decision-making in clinic incredibly fast and convenient.4 I’ve also been impressed with the level of overall vision and near vision that the 3 Add provides to my patients with presbyopia.”5

All-Day Comfort

With a focus on maximizing patient comfort, CooperVision utilized the company’s proprietary Optimized Comfort Edge™—an upgraded edge design initially featured on clariti® 1 day sphere lenses—to provide a high level of comfort from the first fit.6,7

WetLoc® Technology creates a naturally wettable lens that locks in moisture to help keep lenses moist throughout the day, supporting high levels of all-day comfort.

  • High level of comfort from the first fit6,7
  • High levels of all-day comfort

Clear Vision5 & Successful and Easy Fitting3 

The all-new clariti® 1 day multifocal 3 Add features the CooperVision Binocular Progressive System®, an innovative 3 Add design that caters to all levels of presbyopia to provide optimal visual acuity at all distances.5

The degree of clear vision achieved through the new clariti® 1 day multifocal 3 Add provides a real “wow” factor to patients, from neophytes, to spectacle lens and spherical CL wearers, to former contact lens drop-outs. 

Case in point: Dr. Lampa recently refit with success a patient with presbyopia who had dropped out of multifocal contact lenses two years earlier and had since relied on spectacle lenses for her vision correction. 

“The patient had tried several multifocal contact lenses in the past, but every attempt was unsuccessful, until fitting her in the Binocular Progressive System design,” he notes. “As soon as she put on the lenses, the patient immediately reported that she couldn’t remember being able to see that well with a multifocal lens in both her near and distance vision.5 Her comfort was excellent.7 The ease of handling of clariti® 1 day multifocal 3 Add was excellent too.”8

The design also offers a simple yet highly effective fitting process to make it easier for practitioners to fit patients with the right lens, without the need for extended chair time.3

  • At least 83% fit success with the first pair of lenses3,9
  • At least 98% fit success with two pairs of lenses or less3,9,10

More Parameters for More Patients

clariti® 1 day multifocal 3 Add is available in the industry-leading range of +8.00D to -12.00D, providing more sphere powers than any other competitive 1-day multifocal lens, enabling practitioners to fit more patients with presbyopia.11

  • The widest range of any other competitive1-day multifocal lens enabling you to fit more patients11

“If I have a patient who requires a higher prescription, I know that clariti® 1 day multifocal 3 Add will most likely offer it,11 and this is always front of mind,” Dr. Lampa says.

Another advantage: A majority of clariti® 1 day multifocal 3 Add lenses are available in plus and minus quarter steps, which is far beyond what a typical competitive multifocal lens offers,11 Dr. Lampa adds. 

Embrace the Opportunity

Dr. Lampa’s advice to colleagues? Don’t miss out on the new clariti® 1 day multifocal 3 Add opportunity.

“It’s an easy discussion in the exam room,” Dr. Lampa emphasizes. “I tell my patients, ‘The clariti® 1 day multifocal 3 Add is a single use lens that provides good vision5 and comfort,2 and it’s available in your prescription. clariti® 1 day multifocal 3 Add is new. I’m having great success with it. I think you will too.’” 

Learn more about clariti multifocal 3 Add for your patients with presbyopia and discover additional learnings and resources at CooperVision’s Online Success Center.

Dr. Lampa is a Professor at the Pacific University College of Optometry and associate at Silver Falls Eyecare in Silverton, OR.

More Blog Posts
Related posts

*Distance logMAR VA -0.05 vs -0.02 (p < 0.01), near VA 0.06 vs 0.11 (p = 0.02) for BPS vs 2 ADD respectively.

1. CVI data on file, 2022.

2. CVI data on file, 2022. Prospective, crossover, bilateral, subject masked, daily wear, dispensing study (4 clinical sites in U.S.) (n=58 habitual soft MFCL wearers). 

3. CVI data on file 2021. Prospective, double-masked, bilateral, one-week dispensing study with clariti® 1 day multifocal 3 add; n=90 habitual MFCL wearers.

4. CVI data on file 2019. Retrospective analysis; N=55 subjects (110 eyes); DV Rx +1.25D to -3.25D, add powers +1.25 to +2.50DS.

5. CVI data on file 2021. Prospective, double-masked, bilateral, one-week dispensing study with clariti® 1 day multifocal 3 add; with ratings from 85 to 89 out of 100; n=90 habitual MFCL wearers.

6. CVI data on file 2021. Prospective, double-masked, bilateral, one-week dispensing study with clariti® 1 day multifocal 3 add with a rating of 88 out of 100; n=90 habitual MFCL wearers.

7.CVI data on file 2021. Prospective, double-masked, bilateral, one-week dispensing study with clariti® 1 day multifocal 3 add; with a rating of 93 out of 100; n=90 habitual MFCL wearers.

8. CooperVision data on file, 2019. clariti® 1 day Wearer Experience Survey conducted online in U.S., n=298: sphere, toric or multifocal; habitual FRP, DD, and new wearers who purchased clariti® 1 day; strongly or somewhat agree.

9. CVI data on file 2021. Prospective, subject-masked, randomized, bilateral, two-week dispensing study at 5 US sites with MyDay® multifocal; n=58 habitual multifocal contact lens wearers.

10. CVI data on file 2020. Prospective, double-masked, bilateral, one-week dispensing study UK with MyDay® multifocal; n=104 habitual multifocal contact lens wearers.

11. CVI data on file 2024. Based on prescription option combinations (sph and add) available across all daily disposable multifocal soft lenses from CVI, JJV, B+L and Alcon in USA Feb 2024.